MAPK
ターゲットにより製品を見付けてください
亜型選択性的な製品
SelleckはPD1/PDL1治療用抗体の販売を開始しました！（Pembrolizumab，Atezolizumab，Nivolumab）
- ホームページ
- 阻害剤
研究分野別
- PI3K/Akt/mTOR
- Epigenetics
- Methylation
- Immunology & Inflammation
- Protein Tyrosine Kinase
- Angiogenesis
- Apoptosis
- Autophagy
- ER stress & UPR
- JAK/STAT
- MAPK
- Cytoskeletal Signaling
- Cell Cycle
- HTS化合物ライブラリー
- FDA-approved Drug Library
- Drug Repurposing Library
- Preclinical and Clinical Compound Library
- Bioactive Compound Library-I
- Bioactive Compound Library-Ⅱ
- Kinase Inhibitor Library
- Express-Pick Library
- Natural Product Library
- Human Endogenous Metabolite Library
- Angiogenesis Related compound Library
- Anti-alzheimer's Disease Compound Library
- Antibiotics Library
- Anti-cancer Compound Library
- Anti-cancer Metabolism Compound Library
- Anti-diabetic Compound Library
- Anti-infection Compound Library
- Apoptosis Compound Library
- Autophagy Compound Library
- Cambridge Cancer Compound Library
- Cell Cycle compound library
- CNS-Penetrant Compound Library
- Covalent Inhibitor Library
- DNA Damage/DNA Repair compound Library
- Epigenetics Compound Library
- Fragment Library
- GPCR Compound Library
- Highly Selective Inhibitor Library
- Histone modification compound library
- HTS Library for Drug Discovery
- Immunology/Inflammation Compound Library
- Inhibitor Library
- Ion Channel Ligand Library
- JAK/STAT compound library
- MAPK Inhibitor Library
- Metabolism Compound Library
- Neuronal Signaling Compound Library
- NF-κB Signaling Compound Library
- PI3K/Akt Inhibitor Library
- Protease Inhibitor Library
- Small Molecule Immuno-Oncology Compound Library
- Stem Cell Signaling Compound Library
- TGF-beta/Smad compound library
- Tyrosine Kinase Inhibitor Library
- Ubiquitination Compound Library
- 動物実験用抗体
- 新製品
- お問い合わせ
